166 related articles for article (PubMed ID: 30814781)
1. Invasive Aspergillosis After Kidney Transplant-Treatment Approach.
Trnacevic S; Mujkanovic A; Nislic E; Begic E; Karasalihovic Z; Cickusic A; Trnacevic A; Halilovic MA
Med Arch; 2018 Dec; 72(6):456-458. PubMed ID: 30814781
[TBL] [Abstract][Full Text] [Related]
2. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis.
Thomas A; Korb V; Guillemain R; Caruba T; Boussaud V; Billaud E; Prognon P; Begué D; Sabatier B
J Clin Pharm Ther; 2010 Feb; 35(1):49-53. PubMed ID: 20175811
[TBL] [Abstract][Full Text] [Related]
3. [Cardiac invasive aspergillosis in a heart transplant recipient].
Eworo A; Muñoz P; Yáñez JF; Palomo J; Guembe P; Roda J; Valerio M; Guinea J; Bouza E
Rev Iberoam Micol; 2011; 28(3):134-8. PubMed ID: 21700234
[TBL] [Abstract][Full Text] [Related]
4. Renal Allograft Aspergillus Infection Presenting With Obstructive Uropathy: A Case Report.
Sadagah L; Alharbi M; Alshomrani M; Almalki A
Transplant Proc; 2017; 49(1):193-197. PubMed ID: 28104135
[TBL] [Abstract][Full Text] [Related]
5. A case of primary cutaneous aspergillosis in a renal transplant recipient.
Park SB; Kang MJ; Whang EA; Han SY; Kim HC; Park KK
Transplant Proc; 2004 Sep; 36(7):2156-7. PubMed ID: 15518783
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
7. Caspofungin as first-line therapy for the treatment of invasive aspergillosis after thoracic organ transplantation.
Groetzner J; Kaczmarek I; Wittwer T; Strauch J; Meiser B; Wahlers T; Daebritz S; Reichart B
J Heart Lung Transplant; 2008 Jan; 27(1):1-6. PubMed ID: 18187079
[TBL] [Abstract][Full Text] [Related]
8. Rituximab induction therapy in highly sensitized kidney transplant recipients.
Yin H; Wan H; Hu XP; Li XB; Wang W; Liu H; Ren L; Zhang XD
Chin Med J (Engl); 2011 Jul; 124(13):1928-32. PubMed ID: 22088448
[TBL] [Abstract][Full Text] [Related]
9. Pituitary aspergillosis in a kidney transplant recipient and review of the literature.
Vijayvargiya P; Javed I; Moreno J; Mynt MA; Kotapka M; Zaki R; Ortiz J
Transpl Infect Dis; 2013 Oct; 15(5):E196-200. PubMed ID: 24093964
[TBL] [Abstract][Full Text] [Related]
10. Twice-Weekly Tacrolimus Can Overcome Pharmacologic Interaction and Help in the Successful Treatment of Pulmonary Aspergillosis in a Liver Transplant Recipient.
Chiu YC; Ho MH; Chen TW; Hsieh CB; Fan HL
Exp Clin Transplant; 2019 Dec; 17(6):838-840. PubMed ID: 30373507
[TBL] [Abstract][Full Text] [Related]
11. Invasive aspergillosis successfully treated by combined antifungal therapy and immunosuppressive monotherapy two months following heart transplantation.
Urbanowicz T; Żabicki B; Baszyńska-Wachowiak H; Straburzyńska-Migaj E; Juszkat R; Grajek S; Jemielity M
Kardiochir Torakochirurgia Pol; 2016 Jun; 13(2):164-8. PubMed ID: 27516796
[TBL] [Abstract][Full Text] [Related]
12. Voriconazole in the treatment of invasive aspergillosis in kidney transplant recipients.
Veroux M; Corona D; Gagliano M; Sorbello M; Macarone M; Cutuli M; Giuffrida G; Morello G; Paratore A; Veroux P
Transplant Proc; 2007; 39(6):1838-40. PubMed ID: 17692627
[TBL] [Abstract][Full Text] [Related]
13. Invasive aspergillosis in kidney transplant recipients: a cohort study.
Pérez-Sáez MJ; Mir M; Montero MM; Crespo M; Montero N; Gómez J; Horcajada JP; Pascual J
Exp Clin Transplant; 2014 Apr; 12(2):101-5. PubMed ID: 24702140
[TBL] [Abstract][Full Text] [Related]
14. Long-term remission of recurrent severe anemia as a result of parvovirus B19 infection in a pediatric renal transplant recipient.
Shen Q; Xu H; Cao Q; Zhou LJ; Xu J; Fang XY; Ge J
Pediatr Transplant; 2011 Jun; 15(4):E76-9. PubMed ID: 20136725
[TBL] [Abstract][Full Text] [Related]
15. [Role of anidulafungin in solid organ transplant recipients].
Aguado JM; Ayats J
Enferm Infecc Microbiol Clin; 2008 Dec; 26 Suppl 14():29-34. PubMed ID: 19572432
[TBL] [Abstract][Full Text] [Related]
16. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients.
Lü TM; Yang SL; Wu WZ; Tan JM
Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554
[TBL] [Abstract][Full Text] [Related]
17. Combination of Total Lymphoid Irradiation, Low-Dose IVIG and ATG as Rescue Therapy for Highly Sensitized and Antibody-Mediated Rejection Renal Transplant Recipients.
Zhu D; Qi G; Tang Q; Li L; Yang C; Lin M; Wu B; Xu M; Cai J; Zhu T; Rong R
Clin Transpl; 2014; ():215-21. PubMed ID: 26281148
[TBL] [Abstract][Full Text] [Related]
18. Rescue therapy with tacrolimus and mycophenolate mofetil does not prevent deterioration of graft function in C4d-positive chronic allograft nephropathy.
Schwarz C; Regele H; Huttary N; Wahrmann M; Exner M; Nagy-Bojarsky K; Kletzmayr J; Hörl WH; Böhmig GA
Wien Klin Wochenschr; 2006 Jul; 118(13-14):397-404. PubMed ID: 16865644
[TBL] [Abstract][Full Text] [Related]
19. [Fever and cavitary infiltrate in a renal transplant recipient].
Rocamora N; Tormo AM; Franco A; Alvarez Avellán L; Olivares J
Nefrologia; 2004; 24 Suppl 3():16-20. PubMed ID: 15219062
[TBL] [Abstract][Full Text] [Related]
20. Administration of Antithymocyte Globulin (Rabbit) to Treat a Severe, Mixed Rejection Episode in a Pregnant Renal Transplant Recipient.
Kutzler HL; Ye X; Rochon C; Martin ST
Pharmacotherapy; 2016 Apr; 36(4):e18-22. PubMed ID: 26892892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
